Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Tesco Corporation (USA) (TESO)?

Page 1 of 2

Is Tesco Corporation (USA) (NASDAQ:TESO) a good investment?

To the average investor, there are a multitude of methods shareholders can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best investment managers can outclass their index-focused peers by a superb amount (see just how much).

Just as key, optimistic insider trading sentiment is another way to analyze the financial markets. Just as you’d expect, there are lots of reasons for an executive to downsize shares of his or her company, but just one, very obvious reason why they would buy. Many academic studies have demonstrated the impressive potential of this tactic if you understand what to do (learn more here).

Keeping this in mind, let’s study the newest info surrounding Tesco Corporation (USA) (NASDAQ:TESO).

Tesco Corporation (USA) (NASDAQ:TESO)

How have hedgies been trading Tesco Corporation (USA) (NASDAQ:TESO)?

In preparation for the third quarter, a total of 12 of the hedge funds we track held long positions in this stock, a change of -8% from the previous quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were upping their holdings meaningfully.

According to our 13F database, Chuck Royce’s Royce & Associates had the largest position in Tesco Corporation (USA) (NASDAQ:TESO), worth close to $34.9 million, accounting for 0.1% of its total 13F portfolio. Coming in second is Cliff Asness of AQR Capital Management, with a $9.4 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other hedgies that hold long positions include Israel Englander’s Millennium Management, John Overdeck and David Siegel’s Two Sigma Advisors and D. E. Shaw’s D E Shaw.

As Tesco Corporation (USA) (NASDAQ:TESO) has experienced declining interest from the smart money’s best and brightest, it’s safe to say that there lies a certain “tier” of hedge funds that decided to sell off their positions entirely in Q1. At the top of the heap, Mike Vranos’s Ellington said goodbye to the largest investment of all the hedgies we track, totaling an estimated $0.3 million in stock. Steven Cohen’s fund, SAC Capital Advisors, also dropped its stock, about $0.2 million worth. These transactions are important to note, as aggregate hedge fund interest was cut by 1 funds in Q1.

What have insiders been doing with Tesco Corporation (USA) (NASDAQ:TESO)?

Bullish insider trading is most useful when the company in question has seen transactions within the past six months. Over the last 180-day time period, Tesco Corporation (USA) (NASDAQ:TESO) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Tesco Corporation (USA) (NASDAQ:TESO). These stocks are TETRA Technologies, Inc. (NYSE:TTI), Newpark Resources Inc (NYSE:NR), Synergy Resources Corp (NYSEAMEX:SYRG), Basic Energy Services, Inc (NYSE:BAS), and Willbros Group Inc (NYSE:WG). All of these stocks are in the oil & gas equipment & services industry and their market caps are similar to TESO’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!